Capgras Syndrome Comorbid With Paranoid Schizophrenia: A Case Report

2019 ◽  
pp. 1
Author(s):  
İbrahim Yağcı ◽  
Yasin Taşdelen
Keyword(s):  
Case Report ◽  
Paranoid Schizophrenia ◽  
Capgras Syndrome

scholarly journals Capgras syndrome in substance-induced psychosis

2018 ◽  
Vol 10 (2) ◽  
Author(s):  
Bharat R. Sampathi ◽  
Anna Sofine ◽  
John Alvarez ◽  
Robert G. Bota
Keyword(s):  
Fatty Acids ◽  
Substance Use ◽  
Case Report ◽  
Family Member ◽  
Delusional Disorder ◽  
Psychiatric History ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Capgras Syndrome ◽  
Oxidative Effects

Capgras Syndrome is a subcategory of delusional disorder. People affected by this syndrome believe that a close associate such as a friend or family member has been replaced by an identical imposter. This case report describes a 23-year-old woman with no prior psychiatric history, whom developed Capgras syndrome, via folie a deux, in the setting of poly-substance use. In this patient, a combination of Aripiprazole 10 mg daily and Escitalopram 10 mg daily were effective in resolving symptoms. Clonazepam was utilized for anxiety and Omega-3 fatty acids 1 g for anti-oxidative effects. Further studies are needed to investigate the effects of a variety of causes and treatments for Capgras Syndrome.

Chronic non-fatal Datura abuse in a patient of paranoid schizophrenia: A case report

2015 ◽  
Vol 43 ◽  
pp. 39-41 ◽  
Author(s):  
Sourav Khanra ◽  
C.R.J. Khess ◽  
Naveen Srivastava
Keyword(s):  
Case Report ◽  
Paranoid Schizophrenia

scholarly journals Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review

2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
Ruohollah Seddigh ◽  
Somayeh Azarnik ◽  
Amir-Abbas Keshavarz-Akhlaghi
Keyword(s):  
Clinical Trials ◽  
Treatment Outcome ◽  
Case Report ◽  
Thyroid Hormones ◽  
Antipsychotic Drugs ◽  
Paranoid Schizophrenia ◽  
Controlled Clinical Trials ◽  
Normal Thyroid ◽  
Normal Thyroid Function ◽  
Thyroid Abnormalities

There are many reports that show different thyroid abnormalities in schizophrenia without clear establishment of their role in etiology and treatment outcome of schizophrenia. Among these reports, there are only a few that consider a role for thyroid hormones as augmenting agents in the treatment with antipsychotic drugs. This case report outlines symptom subsidence of a patient with clozapine refractory paranoid schizophrenia and normal thyroid function who added levothyroxine to clozapine and found that symptoms of psychosis returned once levothyroxine was discontinued. Although this observation needs to be confirmed in controlled clinical trials, we aimed to discuss possible hypothesized mechanisms underlying this observation.

scholarly journals Capgras syndrome as a psychiatric manifestation in Parkinson's disease: A case report and literature review

2015 ◽  
Vol 17 (66) ◽  
pp. 49-52 ◽  
Author(s):  
I. Estrada-Bellmann ◽  
Y. Ulloa-Escobar ◽  
S.L. Barbosa-Flores ◽  
R.E. Pech-George ◽  
R. González-Treviño ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Case Report ◽  
Literature Review ◽  
Psychiatric Manifestation ◽  
Capgras Syndrome

A Case Report of a Capgras’ Syndrome in Elderly

2016 ◽  
Vol 33 (S1) ◽  
pp. S472-S472
Author(s):  
C. Moreno Menguiano ◽  
M. Gutierrez Rodriguez ◽  
F. Garcia Sanchez ◽  
S. Bravo Herrero
Keyword(s):  
Cognitive Impairment ◽  
Case Report ◽  
Single Case ◽  
Psychiatric Disease ◽  
Her Family ◽  
Single Case Report ◽  
Pubmed Database ◽  
Capgras Syndrome ◽  
Competing Interest ◽  
Close Relatives

IntroductionCapgras syndrome is the most frequent delusional misidentification syndrome (DMS) which was first described in 1923 by Capgras and Reboul-Lachaux as ‘L’illusion des sosies’. Consists of believe that close relatives have been replaced by nearly identical impostors. It can occur in the context of psychiatric disorders (schizophrenia, major depression) such organic, in which onset of delirium is usually later coinciding with neurological damage or neurodegenerative disease.Case reportWoman 73-year-old diagnosed of schizophrenia since more than thirty years ago. Her family talk about general impairment of the patient in the last two years. She needed a couple of psychiatric hospitalizations because of her psychiatric disease, and probably onset of cognitive impairment. In this context, we objectified the presence of a Capgras syndrome.ObjectivesTo review the literature available about Capgras syndrome in elderly and illustrate it with a clinical case.MethodsReview of literature about Capgras syndrome in elderly by searching of articles in the PubMed database of the last five years to illustrate the exposure of a single case report.ResultsThe etiology of this syndrome is not yet well understood. Advanced age is frequently found Capgras syndrome with or without the concomitant presence of an obvious cognitive impairment.ConclusionsSince it is a complex process an etiological model that combines cognitive and perceptual deficits, organic impairment and psychodynamic factors should be proposed. And it is important to make a correct differential diagnosis that allows us to carry out the best possible treatment.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Clozapine-induced rabbit syndrome: a case report

2009 ◽  
Vol 1 (1) ◽  
pp. 1-3 ◽  
Author(s):  
Cicek Hocaoglu
Keyword(s):  
Case Report ◽  
Female Patient ◽  
Case History ◽  
Atypical Antipsychotics ◽  
Paranoid Schizophrenia ◽  
Background Information ◽  
Clozapine Treatment ◽  
History Of ◽  
Typical Antipsychotics

Rabbit syndrome (RS) is an antipsychoticinduced rhythmic motion of the mouth/lips resembling the chewing movements of a rabbit. The movement consists of a vertical-only motion, at about 5 Hz, with no involvement of the tongue. Long-term exposure to typical antipsychotics has clearly been associated with RS, but little is known of the risk of RS due to exposure to newer atypical antipsychotics. There have been isolated reports of RS in patients treated with the atypical agents risperidone, aripiprazole, olanzapine, and clozapine. We present the case history of a 44-year old female patient treated for paranoid schizophrenia for 22 years and RS during her last 10-month clozapine treatment. Background information from the literature is also discussed.

Trazodone and exacerbation of psychotic symptoms: an unfamiliar link

2014 ◽  
Vol 32 (4) ◽  
pp. 337-339 ◽  
Author(s):  
M. Osman ◽  
M. Kilduff
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Paranoid Schizophrenia ◽  
Psychotic Symptoms

ObjectiveIn this case report we attempt to emphasize the unfamiliar link between trazodone and relapse of psychotic symptoms.MethodCase report and literature review of relevant papers.ResultsWe report a case of a 78-year-old woman with an established diagnosis of paranoid schizophrenia who has experienced an exacerbation of positive psychotic symptoms following initiation of 50 mg dailydose of trazodone. We noted that psychotic symptoms abated following discontinuation of trazodone.ConclusionTrazodone use in patients in remission from schizophrenia may be associated with relapse of psychotic symptoms and caution is required.

The Capgras Syndrome? A Rarity

1968 ◽  
Vol 2 (1) ◽  
pp. 44-45 ◽  
Author(s):  
J. R. B. Ball ◽  
M. A. Kidson
Keyword(s):  
Paranoid Schizophrenia ◽  
Capgras Syndrome

The history is presented of a case of the Capgras Syndrome occurring in Paranoid Schizophrenia. It is suggested that the syndrome is rarely reported but may be more prevalent than has been previously thought.

Sign in / Sign up

Export Citation Format

Share Document